Header Logo

Connection

Yehuda Handelsman to Injections, Subcutaneous

Back to Details
This is a "connection" page, showing publications Yehuda Handelsman has written about Injections, Subcutaneous.
Yehuda Handelsman
Connection Strength
0.137
Injections, Subcutaneous
  1. Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II. Diabetes Obes Metab. 2017 07; 19(7):989-996.
    View in: PubMed
    Score: 0.137
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.